272 related articles for article (PubMed ID: 37421458)
21. Identification of Prognostic and Tumor Microenvironment by Shelterin Complex-Related Signatures in Oral Squamous Cell Carcinoma.
Zhang S; Yu H; Li J; Zhao L; Tan L; Song Q; Sun C
Oxid Med Cell Longev; 2022; 2022():6849304. PubMed ID: 35757510
[TBL] [Abstract][Full Text] [Related]
22. A prognostic Risk Score model for oral squamous cell carcinoma constructed by 6 glycolysis-immune-related genes.
Liu Y; Wang T; Li R
BMC Oral Health; 2022 Aug; 22(1):324. PubMed ID: 35922788
[TBL] [Abstract][Full Text] [Related]
23. A Prognostic Model Based on Cisplatin-Resistance Related Genes in Oral Squamous Cell Carcinoma.
Lu R; Yang Q; Liu S; Sun L
Oral Health Prev Dent; 2024 Jan; 22():39-50. PubMed ID: 38223960
[TBL] [Abstract][Full Text] [Related]
24. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.
Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X
Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461
[TBL] [Abstract][Full Text] [Related]
25. Improved antitumor immunity of chemotherapy in OSCC treatment by Gasdermin-E mediated pyroptosis.
Zi M; Xingyu C; Yang C; Xiaodong S; Shixian L; Shicheng W
Apoptosis; 2023 Apr; 28(3-4):348-361. PubMed ID: 36370260
[TBL] [Abstract][Full Text] [Related]
26. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
27. A novel pyroptosis-related lncRNA prognostic signature associated with the immune microenvironment in lung squamous cell carcinoma.
Zhou W; Zhang W
BMC Cancer; 2022 Jun; 22(1):694. PubMed ID: 35739504
[TBL] [Abstract][Full Text] [Related]
28. [MicroRNA model that can predict the prognosis of oral squamous cell carcinoma based on bioinformatics analysis].
Zhao G; Li CX; Guo C; Zhu H
Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Dec; 38(6):622-627. PubMed ID: 33377337
[TBL] [Abstract][Full Text] [Related]
29. Pyroptosis-related gene-based prognostic signature for predicting the overall survival of oral squamous cell carcinoma patients.
Zeng D; Wang X; Zhang S; Zheng A; Huang Q; Cao L
Front Surg; 2022; 9():903271. PubMed ID: 36061051
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of Synuclein-
Yang J; Pan Y; Peng L; Zhang L; Zhao J; Zheng Z; Zheng J; Xu X; Zeng Y
Biomed Res Int; 2022; 2022():6534626. PubMed ID: 35434126
[TBL] [Abstract][Full Text] [Related]
31. Construction and comprehensive analysis of a novel prognostic signature associated with pyroptosis molecular subtypes in patients with pancreatic adenocarcinoma.
Huang Q; Peng X; Li Q; Zhu J; Xue J; Jiang H
Front Immunol; 2023; 14():1111494. PubMed ID: 36817451
[TBL] [Abstract][Full Text] [Related]
32. Ubiquitination, SUMOylation, and NEDDylation related genes serve as prognostic and therapeutic biomarkers for oral squamous cell carcinoma.
Deng SZ; Wu X; Kong L; Cheng B; Dai L
J Oral Pathol Med; 2024 Feb; 53(2):114-123. PubMed ID: 38234119
[TBL] [Abstract][Full Text] [Related]
33. A novel and independent survival prognostic model for OSCC: the functions and prognostic values of RNA-binding proteins.
Wang S; Liu S; Zhu Y; Zhang B; Yang Y; Li L; Sun Y; Zhang L; Fan L; Hu X; Huang C
Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):397-409. PubMed ID: 37656222
[TBL] [Abstract][Full Text] [Related]
34. A risk model based on pyroptosis subtypes predicts tumor immune microenvironment and guides chemotherapy and immunotherapy in bladder cancer.
Wu T; Li S; Yu C; Wu Y; Long H
Sci Rep; 2022 Dec; 12(1):21467. PubMed ID: 36509838
[TBL] [Abstract][Full Text] [Related]
35. A novel and robust pyroptosis-related prognostic signature predicts prognosis and response to immunotherapy in esophageal squamous cell carcinoma.
Zhang D; Zhao F; Li J; Qin X; Li S; Niu R
Aging (Albany NY); 2023 Aug; 15(15):7811-7830. PubMed ID: 37561524
[TBL] [Abstract][Full Text] [Related]
36. Establishment and Analysis of Hypoxia-Related Model in Oral Squamous Cell Carcinoma.
Lu X; Liu X
J Healthc Eng; 2022; 2022():6602648. PubMed ID: 35432823
[TBL] [Abstract][Full Text] [Related]
37. Multiomics data analyses to identify SLC25A17 as a novel biomarker to predict the prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Shi Y; Huang J; Hu Y; Shen Y
BMC Bioinformatics; 2023 Jun; 24(1):269. PubMed ID: 37386359
[TBL] [Abstract][Full Text] [Related]
38. Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients.
Li H; Zhang X; Yi C; He Y; Chen X; Zhao W; Yu D
BMC Cancer; 2021 Jul; 21(1):835. PubMed ID: 34284753
[TBL] [Abstract][Full Text] [Related]
39. Identification and Validation of a Prognostic Signature Derived from the Cancer Stem Cells for Oral Squamous Cell Carcinoma.
Shi M; Huang K; Wei J; Wang S; Yang W; Wang H; Li Y
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256104
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the m
Pan L; She H; Wang K; Xia W; Tang H; Fan Y; Ye J
Sci Rep; 2023 Apr; 13(1):6617. PubMed ID: 37095314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]